全文获取类型
收费全文 | 111753篇 |
免费 | 7836篇 |
国内免费 | 3262篇 |
专业分类
耳鼻咽喉 | 558篇 |
儿科学 | 2856篇 |
妇产科学 | 2230篇 |
基础医学 | 17468篇 |
口腔科学 | 2162篇 |
临床医学 | 6767篇 |
内科学 | 19644篇 |
皮肤病学 | 1720篇 |
神经病学 | 13147篇 |
特种医学 | 2813篇 |
外国民族医学 | 22篇 |
外科学 | 10053篇 |
综合类 | 10350篇 |
现状与发展 | 10篇 |
预防医学 | 4918篇 |
眼科学 | 1042篇 |
药学 | 16699篇 |
32篇 | |
中国医学 | 2260篇 |
肿瘤学 | 8100篇 |
出版年
2023年 | 1312篇 |
2022年 | 2550篇 |
2021年 | 3864篇 |
2020年 | 3243篇 |
2019年 | 4250篇 |
2018年 | 4301篇 |
2017年 | 3485篇 |
2016年 | 3164篇 |
2015年 | 3523篇 |
2014年 | 5899篇 |
2013年 | 7144篇 |
2012年 | 5223篇 |
2011年 | 5917篇 |
2010年 | 4904篇 |
2009年 | 5133篇 |
2008年 | 5269篇 |
2007年 | 4834篇 |
2006年 | 4262篇 |
2005年 | 3631篇 |
2004年 | 3369篇 |
2003年 | 3102篇 |
2002年 | 2459篇 |
2001年 | 2195篇 |
2000年 | 1984篇 |
1999年 | 1773篇 |
1998年 | 1857篇 |
1997年 | 1699篇 |
1996年 | 1513篇 |
1995年 | 1226篇 |
1994年 | 1123篇 |
1993年 | 965篇 |
1992年 | 751篇 |
1991年 | 710篇 |
1990年 | 544篇 |
1989年 | 469篇 |
1988年 | 419篇 |
1986年 | 373篇 |
1985年 | 1366篇 |
1984年 | 2102篇 |
1983年 | 1287篇 |
1982年 | 1478篇 |
1981年 | 1390篇 |
1980年 | 1122篇 |
1979年 | 977篇 |
1978年 | 859篇 |
1977年 | 729篇 |
1976年 | 824篇 |
1975年 | 590篇 |
1974年 | 511篇 |
1973年 | 563篇 |
排序方式: 共有10000条查询结果,搜索用时 493 毫秒
71.
72.
《Journal of Clinical Orthopaedics and Trauma》2019,10(2):380-386
Additive manufacturing is a rapidly emerging technology which is being successfully implemented in the various field of medicine as well as in orthopaedics, where it has applications in reducing cartilage defects and treatments of bones. The technology helps through systematic collection of information about the shape of the "defects" and precise fabrication of complex 3D constructs such as cartilage, heart valve, trachea, myocardial bone tissue and blood vessels. In this paper, a large number of the relevant research papers on the additive manufacturing and its application in medical specifically orthopaedics are identified through Scopus had been studied using Bibliometric analysis and application analysis is undertaken. The bibliometric analysis shows that there is an increasing trend in the research reports on additive manufacturing applications in the field of orthopaedics. Discussions are on using technological advancement like scanning techniques and various challenges of the orthopaedic being met by additive manufacturing technology. For patient-specific orthopaedic applications, these techniques incorporate clinical practice and use for effective planning. 3D printed models printed by this technology are accepted for orthopaedic surgery such as revision of lumbar discectomy, pelvic surgery and large scapular osteochondroma. The applications of additive manufacturing in orthopaedics will experience a rapid translation in future. An orthopaedic surgeon can convert need/idea into a reality by using computer-aided design (CAD) software, analysis software to facilitate the manufacturing. Thus, AM provides a comprehensive opportunity to manufacture orthopaedic implantable medical devices. 相似文献
73.
《Journal of thoracic oncology》2021,16(9):1449-1460
Pulmonary immune-related adverse events represent rare but potentially severe side effects of immunotherapies. Diagnosis is often challenging, as symptoms and imaging features are not specific and may mimic other lung diseases, thus potentially delaying appropriate patient management. In this setting, an accurate imaging evaluation is essential for a prompt detection and correct management of these drug-induced lung diseases. The purpose of this article is to review the different types of pulmonary immune-related adverse events, describe their imaging characteristics on both high-resolution computed tomography and positron emission tomography/computed tomography and stress their underlying diagnostic challenge by presenting the mimickers. 相似文献
74.
75.
OBJECTIVES: To assess the effectiveness and safety of additional bedtime H2‐receptor antagonists (H2RAs) in suppressing nocturnal gastric acid breakthrough (NAB) via a systematic review. METHODS: Eligible trials were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 2, 2004), MEDLINE (January 1966–June 2004), EMBASE (January 1980–June 2004) and CINAHL (January 1982–June 2004). Additional hand‐searching was conducted on the proceedings of correlated conferences, eight important Chinese journals and references of all included trials. All randomized controlled trials evaluating H2RAs for the control of NAB were eligible for inclusion. The systematic review was conducted using methods recommended by The Cochrane Collaboration. RESULTS: Only two randomized crossover studies, comprising 32 participants, met the inclusion criteria. Because the design, dosage and duration of the treatments were different between the studies, it was not possible to conduct meta‐analysis. There were no consistent conclusions found between the two included studies in evaluating H2RAs for the control of NAB. CONCLUSIONS: No implications for practice at this stage can be concluded. Appropriately designed large‐scale randomized controlled trials with long‐term follow up are needed to determine the effects of additional bedtime H2RAs in suppressing NAB. 相似文献
76.
Tetsuo Shoji Yoshiki Nishizawa 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2006,10(Z1):S27-S33
Abstract: The risk of cardiovascular death is high in hemodialysis (HD) patients, and thickening, stiffening and calcification of the arterial wall have been shown as its predictive factors. Activated vitamin D preparations are used for the treatment of secondary hyperparathyroidism in HD patients, but as they increase serum phosphate and calcium concentrations, there is a concern that they promote vascular calcification and, consequently, exacerbate the outcomes. In this article, the effects of vitamin D therapy on survival, cardiac function, arteriosclerosis, immunity, and inflammation are evaluated by reviewing the literature. In HD patients, the risk of death (particularly cardiovascular death) is significantly lower in those treated than in those not treated with vitamin D. Moreover, activated vitamin D improves cardiac function and alleviates cardiac hypertrophy in HD patients. Experimental data in cultured macrophages, vascular smooth muscle cells, and vascular endothelial cells suggest that it has antiatherosclerotic effects. In vivo, the administration of vitamin D improves immune functions and normalizes inflammatory reactions. In HD patients, vascular calcification is related to the dose of calcium carbonate, but its relationship with the administration of vitamin D is not significant. These observations suggest that, contrary to the general concerns, activated vitamin D exerts favorable effects on the cardiovascular system in HD patients as long as it is used in appropriate clinical doses. 相似文献
77.
A method is presented for 3D MRI in an extended field of view (FOV) based on continuous motion of the patient table and an efficient acquisition scheme. A gradient-echo MR pulse sequence is applied with lateral (left-right (L/R)) frequency-encoding direction and slab selection along the direction of motion. Compensation for the table motion is achieved by a combination of slab tracking and data alignment in hybrid space. The method allows fast k-space coverage to be achieved, especially when a short sampling FOV is chosen along the direction of table motion, as is desirable for good image quality. The method can be incorporated into different acquisitions schemes, including segmented k-space scanning, which allows for contrast variation with the use of magnetization preparation. Head-to-toe images of volunteers were obtained with good quality using 3D spoiled gradient-echo sequences. As an example of magnetization-prepared imaging, fat/water separated images were acquired using chemical shift selective (CHESS) presaturation pulses. 相似文献
78.
目的探讨谷氨酸是否能够影响腺苷A2A受体对一氧化氮合酶(NOS)活力的调节。方法用1000ng/ml脂多糖(LPS)刺激小胶质细胞,分别加入100nmol/L A2A受体激动剂CGS21680以及不同浓度的谷氨酸(0,1,0,25,0,5mmol/L)干预,观察NOS活力变化。结果LPS诱导NOS活力增高,激活A2A受体可以产生抑制作用;0,25及0.5mmoL/L谷氨酸和A2A受体激动剂同时存在时,NOS活力进一步增高。结论高浓度谷氨酸可逆转腺苷A2A受体激动剂抑制升高NOS活力的作用。 相似文献
79.
通过分析中国马拉松运动员ACE基因I/D多态频率分布特征,探讨其作为杰出耐力基因标记的可行性。选择我国马拉松健将、国际健将级运动员26名作为马拉松运动员组,汉族学生216名作为对照组。对两组受试者进行ACE基因I/D多态性测定。结果显示:我国马拉松运动员组的等位基因频率和基因型频率与对照组比较无显著差异,其中15名国际健将中无一DD型纯合子,提示我国优秀马拉松运动员的纯合子DD型频率低下是其ACE基因多态频率分布的主要特征。 相似文献
80.
小颗粒致密低密度脂蛋白氧化特性及对血管内皮细胞脂质过氧化的影响 总被引:6,自引:1,他引:5
了解小颗粒致密低密度脂蛋白中抗氧化维生素含量、氧化特性 ,探讨其对血管内皮细胞脂质过氧化的影响。采用二次密度梯度超速离心的方法分离制备小颗粒致密低密度脂蛋白 ,高压液相色谱测定其抗氧化物质维生素A、E和 β 胡萝卜素 ;连续监测小颗粒致密低密度脂蛋白在 2 34nm的吸光度以测定其氧化敏感曲线 ;在血管内皮培养液中分别加入不同浓度的小颗粒致密低密度脂蛋白 ,培养后测定培养液丙二醛的浓度。实验成功分离小颗粒致密低密度脂蛋白 ,与大而轻低密度脂蛋白相比 ,维生素A、E和 β 胡萝卜素等抗氧化物质及总抗氧化能力明显减少 ,只有大而轻低密度脂蛋白的 6 5 %、39%和 2 4 % ,故小颗粒致密低密度脂蛋白氧化的延迟时间只有大而轻低密度脂蛋白的 37.5 % ,但硫代巴比妥酸反应物质值及氧化速率分别是大而轻低密度脂蛋白的 1 .7倍和 1 .2 8倍 ;培养液中丙二醛含量随加入脂蛋白的浓度和作用时间而增高 ,2 4h时小颗粒致密低密度脂蛋白 5 0mg组、1 0 0mg组、1 5 0mg组与相同剂量大而轻低密度脂蛋白组比较丙二醛显著增高 (P <0 .0 5 )。上述结果提示 :小颗粒致密低密度脂蛋白中抗氧化物质及抗氧化能力下降 ,氧化敏感性增高 ,并促进内皮细胞过氧化损伤 相似文献